CareCloud, Inc.
$3.2
▼
-7.46%
2026-04-21 05:56:01
www.carecloud.com
NGM: CCLD
Explore CareCloud, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$135.98 M
Current Price
$3.2
52W High / Low
$4.01 / $1.33
Stock P/E
12.59
Book Value
$1.4
Dividend Yield
4.63%
ROCE
18.2%
ROE
19.76%
Face Value
—
EPS
$0.1
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
3,650
Beta
1.83
Debt / Equity
7.2
Current Ratio
1.05
Quick Ratio
1.03
Forward P/E
7.11
Price / Sales
0.95
Enterprise Value
$115.9 M
EV / EBITDA
7.07
EV / Revenue
0.96
Rating
None
Target Price
$6.31
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
| 2. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 3. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 4. | Healthcare Triangle, Inc. | $2.47 | — | $4.86 M | — | 89.58% | -1.83% | $7,470 / $2.24 | $17.67 |
| 5. | National Research Corporation | $18.18 | 35.65 | $413.53 M | 3.52% | 22.99% | 51.24% | $22.79 / $9.76 | $0.62 |
| 6. | Teladoc Health, Inc. | $6.1 | — | $1.09 B | — | -6.66% | -13.93% | $9.77 / $4.4 | $7.77 |
| 7. | Doximity, Inc. | $24.39 | 19.07 | $4.56 B | — | 20.77% | 23.82% | $76.51 / $20.55 | $5.29 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 34.42 M | 31.07 M | 27.38 M | 27.63 M | 28.24 M | — |
| Operating Profit | 3.12 M | 3.23 M | 3.02 M | 2.13 M | 3.55 M | — |
| Net Profit | 2.89 M | 3.06 M | 2.9 M | 1.95 M | 3.3 M | — |
| EPS in Rs | 0.07 | 0.07 | 0.07 | 0.05 | 0.08 | -0.04 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 120.5 M | 110.84 M | 117.06 M | 138.83 M |
| Operating Profit | 11.5 M | 9.72 M | -4.01 M | 4.66 M |
| Net Profit | 10.8 M | 7.85 M | -48.67 M | 5.43 M |
| EPS in Rs | 0.25 | 0.18 | -1.15 | 0.13 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 87.6 M | 71.61 M | 77.83 M | 136.17 M |
| Total Liabilities | 28.09 M | 21.84 M | 36.11 M | 34.48 M |
| Equity | 59.51 M | 49.77 M | 41.72 M | 101.69 M |
| Current Assets | 25.74 M | 24.8 M | 23.24 M | 34.65 M |
| Current Liabilities | 24.42 M | 19.58 M | 23.3 M | 22.4 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 28.56 M | 20.64 M | 15.46 M | 21.15 M |
| Investing CF | -24.54 M | -7.41 M | -11.61 M | -11.77 M |
| Financing CF | -5.61 M | -11.26 M | -13.29 M | -7.65 M |
| Free CF | 20.53 M | 13.24 M | 3.85 M | 9.38 M |
| Capex | -8.03 M | -7.41 M | -11.61 M | -11.77 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -5.32% | -15.68% | — | — |
| Earnings Growth % | 116.13% | -996.06% | — | — |
| Profit Margin % | 7.08% | -41.58% | 3.91% | — |
| Operating Margin % | 8.77% | -3.43% | 3.36% | — |
| Gross Margin % | 45.11% | 39.5% | 39.18% | — |
| EBITDA Margin % | 22.89% | -26.31% | 15.57% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.